NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Cash Flow Quality Index
Latest as of September 2025:
-0.83x
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Cash Flow Quality Index of -0.83x as of September 2025. Operating cash flow of $-32.77 Million is below net income of $39.53 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NAMS long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.83x
Operating CF / Net Income
Operating Cash Flow
$-32.77 Million
USD
Net Income
$39.53 Million
USD
Data as of
Sep 2025
Most recent filing
Annual Cash Flow Quality Index for NewAmsterdam Pharma Company N.V. Ordinary Shares (None–None)
Year-by-year earnings quality comparison for NewAmsterdam Pharma Company N.V. Ordinary Shares. For live market cap and the full company financial profile, see NAMS market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.